Benign and solid tumors of the liver: relationship to sex, age, size of tumors, and outcome.
From 1983 through 1997, our center diagnosed 130 cases of benign neoplasms: 27 with focal nodular hyperplasia (FNH), 25 with hepatic adenoma, 71 with cavernous hemangioma, and seven with mixed tumors of different diagnoses. Most often these lesions were seen in females [female-to-male ratio (f/m): 5.5/1]. Hepatic adenomas and mixed tumors were seen exclusively in females and FNH predominantly in females (f/m: 26/1). Hemangiomas, however, were not uncommon in men (f/m: 52/19) relative to the other tumors (P < 0.001). Furthermore patients with hemangioma were older (mean age: 49 years) whereas patients with hepatic adenoma, FNH, and mixed tumors were often younger (mean age: 33, 35, and 44 years respectively; P < 0.004). Oral contraceptive steroid use was related by 21 of 25 patients (84%) with hepatic adenoma, 22 of 26 (85%) females with FNH, five of seven (71%) females with mixed tumors, and 10 of 52 (19%) patients with hemangioma. Ninety-five of the 130 patients (73%) had one or more symptoms. There was no statistically significant correlation between symptoms and the size of the lesion, the final diagnosis, and whether there were solitary or multiple masses. Three of 25 (12%) with hepatic adenoma presented with rupture, and one of 27 (4%) with FNH had such a consequence. None of the hemangiomas presented with rupture or progressed to such a state. One patient with hepatic adenoma (4%) had a focus of malignancy. Surgical removal of benign tumors was performed in 82 of 130 patients (63%), and there was one operative mortality (1.2%) in a patient who had a caudate lobe FNH. The types of surgical procedures included segmentectomy (62%), lobectomy (34%), and trisegmentectomy (4%). In two of 84 patients who had undergone laparotomy resection was not technically possible. Resection is recommended in all cases of hepatic adenoma because of fear of rupture or associated focus of malignancy. FNH was not observed to undergo a malignant transformation and will rarely rupture. Surgery is only recommended for symptomatic hemangioma, and size of the lesion is not a criterion for excision.
Reddy
K R
KR
Department of Medicine, Center for Liver Diseases, University of Miami School of Medicine and Veterans Administration Medical Center, Florida 33136, USA.
Kligerman
S
S
Levi
J
J
Livingstone
A
A
Molina
E
E
Franceschi
D
D
Badalamenti
S
S
Jeffers
L
L
Tzakis
A
A
Schiff
E R
ER
D018248:Adenoma, Liver Cell / Q000453:epidemiology / Q000601:surgery; D000328:Adult; D000367:Age Factors; D016208:Databases, Factual; D005260:Female; D020518:Focal Nodular Hyperplasia / Q000453:epidemiology / Q000601:surgery; D006392:Hemangioma, Cavernous / Q000453:epidemiology / Q000601:surgery; D006498:Hepatectomy / Q000379:methods; D006801:Humans; D008113:Liver Neoplasms / Q000453:epidemiology* / Q000601:surgery; D008297:Male; D012189:Retrospective Studies; D012737:Sex Factors